Literature DB >> 35313731

Detection of Mixed Populations of Clarithromycin-Susceptible and -Resistant Mycobacterium abscessus Strains.

Shamira J Shallom1, Adrian M Zelazny1.   

Abstract

Clarithromycin resistance in Mycobacterium abscessus subsp. abscessus, massiliense, and bolletii occurs through induction of erm(41) or mutations in rrl (23S rRNA) genes. Phenotypic detection of clarithromycin resistance is hindered by the need for extended incubation as well as co-occurrence of mixed populations of M. abscessus with different susceptibility profiles. We developed a quantitative EvaGreen-based droplet digital PCR (ddPCR) scheme for rapid detection of full-length or truncated erm(41) and a probe based ddPCR screening assay for assessment of 23S rRNA rrl mutational resistance. We tested 100 M. abscessus strains, synthetic mixes with different susceptibility profiles, and 13 positive MGIT samples. Truncated and full-length erm(41) genes were detected in 27/100 and 73/100 strains and 4/13 and 9/13 MGIT samples, respectively yielding a sensitivity and specificity of 100%. Clarithromycin resistance mutations in rrl were detected in 26/100 isolates, i.e., A2058G (18/100), A2058C (7/100), and A2059G (1/100), and in 3/13 MGIT samples, i.e., A2058G (2/13) and A2059G (1/13). A screening assay of rrl ddPCR (A2058A/A2058G probes) showed 100% sensitivity in detecting the wild type or A2058G mutation as well as identifying samples requiring further testing. Upon inclusion of additional ddPCR assays, we were able to detect A2058C and A2059G clarithromycin resistance-conferring mutations in the rrl gene. Our ddPCR scheme can differentiate between full-length and truncated erm(41) and identify clarithromycin resistance-conferring mutations in the rrl gene from clinical isolates and positive MGIT samples as well as deconvolute and quantitate mixed populations of M. abscessus with different clarithromycin resistance traits.

Entities:  

Keywords:  M. abscessus; antimicrobial susceptibility testing; antimicrobial susceptibility testing (AST); clarithromycin; clarithromycin resistance; diagnostic algorithm; droplet digital PCR (ddPCR); heteroresistance; mycobacterial growth indicator tube (MGIT); resistance

Mesh:

Substances:

Year:  2022        PMID: 35313731      PMCID: PMC9020357          DOI: 10.1128/jcm.01694-21

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   11.677


  31 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Non-tuberculous mycobacterial pulmonary disease.

Authors:  Steven Cowman; Jakko van Ingen; David E Griffith; Michael R Loebinger
Journal:  Eur Respir J       Date:  2019-07-11       Impact factor: 16.671

3.  Rapid one-step protein extraction method for the identification of mycobacteria using MALDI-TOF MS.

Authors:  Suwatchareeporn Rotcheewaphan; Jamie K Lemon; Uma U Desai; Christina M Henderson; Adrian M Zelazny
Journal:  Diagn Microbiol Infect Dis       Date:  2019-03-20       Impact factor: 2.803

4.  Epidemic of surgical-site infections by a single clone of rapidly growing mycobacteria in Brazil.

Authors:  Sylvia Cardoso Leão; Cristina Viana-Niero; Cristianne Kayoko Matsumoto; Karla Valeria Batista Lima; Maria Luiza Lopes; Moisés Palaci; David Jamil Hadad; Solange Vinhas; Rafael Silva Duarte; Maria Cristina Silva Lourenço; André Kipnis; Zilah Cândida das Neves; Betina Mendez Alcântara Gabardo; Marta Osório Ribeiro; Ludmila Baethgen; Denise Brandão de Assis; Geraldine Madalosso; Erica Chimara; Margareth Pretti Dalcolmo
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

5.  Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs.

Authors:  Barbara A Brown-Elliott; Sruthi Vasireddy; Ravikiran Vasireddy; Elena Iakhiaeva; Susan T Howard; Kevin Nash; Nicholas Parodi; Anita Strong; Martha Gee; Terry Smith; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

6.  Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare.

Authors:  A Meier; P Kirschner; B Springer; V A Steingrube; B A Brown; R J Wallace; E C Böttger
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059.

Authors:  Peter Pfister; Simon Jenni; Jacob Poehlsgaard; Ashley Thomas; Stephen Douthwaite; Nenad Ban; Erik C Böttger
Journal:  J Mol Biol       Date:  2004-10-01       Impact factor: 5.469

8.  New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group.

Authors:  Shamira J Shallom; Natalia S Moura; Kenneth N Olivier; Elizabeth P Sampaio; Steven M Holland; Adrian M Zelazny
Journal:  J Clin Microbiol       Date:  2015-08-12       Impact factor: 5.948

9.  A Molecular-Beacon-Based Multiplex Real-Time PCR Assay To Distinguish Mycobacterium abscessus Subspecies and Determine Macrolide Susceptibility.

Authors:  Salvatore A E Marras; Liang Chen; Elena Shashkina; Rebecca M Davidson; Michael Strong; Charles L Daley; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

10.  A real-time PCR assay for rapid identification of inducible and acquired clarithromycin resistance in Mycobacterium abscessus.

Authors:  Meenu Kaushal Sharma; Yanni La; Debra Janella; Hafid Soualhine
Journal:  BMC Infect Dis       Date:  2020-12-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.